Omega Fund Management, LLC Nuvation Bio Inc. Transaction History
Omega Fund Management, LLC
- $67.4 Million
- Q3 2024
A detailed history of Omega Fund Management, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Omega Fund Management, LLC holds 13,072,340 shares of NUVB stock, worth $32 Million. This represents 44.61% of its overall portfolio holdings.
Number of Shares
13,072,340
Previous 13,275,884
1.53%
Holding current value
$32 Million
Previous $38.8 Million
22.44%
% of portfolio
44.61%
Previous 50.57%
Shares
9 transactions
Others Institutions Holding NUVB
# of Institutions
164Shares Held
157MCall Options Held
3.2KPut Options Held
98.7K-
Decheng Capital LLC Menlo Park, CA26MShares$63.6 Million14.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA19.2MShares$47.1 Million1.92% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$39.8 Million0.0% of portfolio
-
Octagon Capital Advisors LP New York, NY12.2MShares$29.8 Million6.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.8MShares$26.5 Million0.0% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $532M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...